Valink Therapeutics
London
About Valink Therapeutics
Valink Therapeutics researches multivalent and combinatorial target approaches intended to address treatment challenges in solid tumors and other therapeutic areas. Its work centers on identifying synergistic and less conventional target pairings and translating them into engineered biologic constructs with defined mechanisms of action. Valink Therapeutics operates as a therapeutics development organization that integrates antibody engineering, payload selection, and linker design within a single discovery framework.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $11.9M
- Funding stage: Seed
- Last round: Seed (Oct 2025)
- Website: valinktx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/valink-therapeutics-34503 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.